ArticleMolecular therapy : the journal of the American Society of Gene Therapy2023

Potential clinical use of azacitidine and MEK inhibitor combination therapy in PTPN11-mutated juvenile myelomonocytic leukemia.

Santhosh Kumar Pasupuleti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.